Tested system to guide botulinum shots for bladder pain
Part of Brain & nervous system, Kidney & urinary, Pain, Women’s health & pregnancy clinical trials.
This early study tests a new medical system that measures pelvic and bladder pain patterns to help guide personalized botulinum toxin (BoNT) injections. It may help women with long-term bladder pain (interstitial cystitis/bladder pain syndrome) by improving how accurately treatment targets the pain source.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 60
- You have a doctor’s diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS)
- Your bladder or pelvic pain has lasted at least 6 months and there’s no other clear cause (like a current infection)
- You have pelvic muscle pain/tenderness and tight pelvic floor muscles (confirmed by an exam and pressure test)
- You are able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a Botox injection into the pelvic floor muscles can reduce chronic pelvic pain. It is for women who have had pelvic pain for at least 6 months, with tender muscle knots in the pelvic area.
This trial tests whether acupuncture can help relieve pain and pressure from bladder pain syndrome (also called interstitial cystitis). Researchers want to see if using acupuncture early can improve symptoms better than usual care.
This study is testing if the type of pain you feel can help predict which treatments work best for interstitial cystitis (a condition that causes bladder pain and pressure). It may help match you with more effective care.
This study tests a new treatment (VNX001) for people with interstitial cystitis or bladder pain syndrome (IC/BPS). You must have already taken part in an earlier study of this drug to join. The goal is to see if it safely reduces bladder pain.
This Phase 2 trial tests VNX001 to see if it helps people with interstitial cystitis/bladder pain syndrome (IC/BPS) compared with its separate ingredients (lidocaine and heparin) or a placebo (inactive treatment). You may be eligible if you have had IC/BPS for months and recently had a moderate-to-severe bladder pain flare.
This trial tests if injecting hyaluronic acid into the bladder wall can safely reduce pain and other symptoms in people with interstitial cystitis/bladder pain syndrome (IC/BPS). It's for those who haven't gotten enough relief from other treatments.
Hear when a new Interstitial Cystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.